POTENSI SENYAWA XANTHORRHIZOL SEBAGAI ANTIFUNGI : NARATIF REVIEW
DOI:
https://doi.org/10.31941/benzena.v2i01.3110Abstract
Xanthorrhizol adalah salah satu fitokimia yang banyak diisolasi dari tanaman Curcuma xanthorrhiza berbagai yang manfaat aktivitas biologis telah dieksplorasi salah satunya sebagai antifungi. Infeksi fungi sering terjadi pada daerah tropis yang menyebabkan penyakit kulit, terjadinya banyak penyakit dan dampak buruk akibat infeksi fungi dalam jangka panjang salah satunya terjadi resistensi obat. Mengingat jamur adalah eukariota seperti inang manusia, target terapi dan keamanan untuk pengembangan antijamur perlu dilakukan. Maka dilakukan pencarian alternatif agen antifungi yang baru seperti xanthorrhizol. Pada tulisan bertujuan untuk mengkaji efek xanthorrhizol sebagai antifungi dari berbagai jenis spesies fungi. Database elektronik seperti Pubmed, ScienceDirect dan Proquest digunakan dalam penulisan ini. Pencarian jurnal dilakukan pada Bulan Mei 2023 yang fokus meneliti senyawa xanthorrhizol sebagai antifungi dengan data nilai MIC sebgai besaran aktivitasnya. Temuan dari tulisan ini menunjukkan bahwa xanthorrhizol menunjukkan penghambatan yang signifikan terhadap fungi panthogen termasuk Candida sp, Malassezia sp, dan Aspergillus sp. Aktivitas xanthorrizol sebagai antifungi dengan menargetkan biofilm dan mengubah morfologi fungi. Efek sinergis diperlihatkan xanthorrizol jika digabungkan dengan ketokonasol dan amphotericin B. Studi mengeksplorasi penggunaan xanthorrhizol sebagai obat potensial untuk pencegahan dan pengobatan berbagai spesias fungi telah menunjukkan hasil yang menjanjikan. Namun, lebih banyak penelitian yang perlu dilakukan terutama di bidang-bidang seperti studi in vitro, in vivo dan klinisDownloads
References
Pianalto KM, Alspaugh JA. New Horizons in Antifungal Therapy. J Fungi (Basel). 2016 Oct 2;2(4):26.
Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012 Dec 19;4(165):165rv13.
Odds FC, Brown AJP, Gow NAR. Antifungal agents: mechanisms of action. Trends Microbiol. 2003 Jun;11(6):272–9.
Rahmat E, Lee J, Kang Y. Javanese Turmeric (Curcuma xanthorrhiza Roxb.): Ethnobotany, Phytochemistry, Biotechnology, and Pharmacological Activities. Zarrelli A, editor. Evidence-Based Complementary and Alternative Medicine [Internet]. 2021 Jun 11 [cited 2021 Oct 27];2021:1–15. Available from: https://www.hindawi.com/journals/ecam/2021/9960813/
Lee HJ, Kang SM, Jeong SH, Chung KH, Kim BI. Antibacterial photodynamic therapy with curcumin and Curcuma xanthorrhiza extract against Streptococcus mutans. Photodiagnosis Photodyn Ther. 2017 Dec;20:116–9.
Hwang JK, Shim JS, Baek NI, Pyun YR. Xanthorrhizol: a potential antibacterial agent from Curcuma xanthorrhiza against Streptococcus mutans. Planta Med. 2000 Mar;66(2):196–7.
Hwang JK, Shim JS, Pyun YR. Antibacterial activity of xanthorrhizol from Curcuma xanthorrhiza against oral pathogens. Fitoterapia. 2000 Jun;71(3):321–3.
Rukayadi Y, Hwang JK. Effect of coating the wells of a polystyrene microtiter plate with xanthorrhizol on the biofilm formation of Streptococcus mutans. J Basic Microbiol. 2006;46(5):410–5.
Roemer T, Krysan DJ. Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med. 2014 May 1;4(5):a019703.
Agarwal V, Lal P, Pruthi V. Prevention of Candida albicans biofilm by plant oils. Mycopathologia. 2008 Jan;165(1):13–9.
Chami N, Bennis S, Chami F, Aboussekhra A, Remmal A. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. Oral Microbiol Immunol. 2005 Apr;20(2):106–11.
Helmerhorst EJ, Reijnders IM, van’t Hof W, Simoons-Smit I, Veerman EC, Amerongen AV. Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agents Chemother. 1999 Mar;43(3):702–4.
Wakabayashi H, Abe S, Teraguchi S, Hayasawa H, Yamaguchi H. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob Agents Chemother. 1998 Jul;42(7):1587–91.
Rukayadi Y, Lee K, Lee MS, Yong D, Hwang JK. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B. FEMS Yeast Res. 2009 Dec;9(8):1302–11.
Rukayadi Y, Han S, Yong D, Hwang JK. In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms. Med Mycol. 2011 Jan;49(1):1–9.
Polak A. The past, present and future of antimycotic combination therapy. Mycoses. 1999;42(5–6):355–70.
Zhu LP, Gil-Lamaignere C, Müller FMC. Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China. Mycoses. 2004 Aug;47(7):319–25.
Cuenca-Estrella M, Gomez-Lopez A, Garcia-Effron G, Alcazar-Fuoli L, Mellado E, Buitrago MJ, et al. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus. Antimicrob Agents Chemother. 2005 Mar;49(3):1232–5.
Rukayadi Y, Hwang JK. In vitro anti-Malassezia activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. Lett Appl Microbiol. 2007 Feb;44(2):126–30.
Rukayadi Y, Hwang JK. In Vitro antimycotic activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. against opportunistic filamentous fungi. Phytother Res. 2007 May;21(5):434–8.
Rukayadi Y, Yong D, Hwang JK. In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. J Antimicrob Chemother. 2006 Jun;57(6):1231–4.
Rukayadi Y, Hwang JK. In Vitro Activity of Xanthorrhizol Isolated from the Rhizome of Javanese Turmeric (Curcuma xanthorrhiza Roxb.) Against Candida albicans Biofilms. Phytotherapy Research [Internet]. 2013 [cited 2023 May 6];27(7):1061–6. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ptr.4834
Downloads
Published
Issue
Section
License
uthors who publish with BENZENA Pharmaceutical Scientific Journal agree to the following terms:- Authors retain copyright and grant the BENZENA Pharmaceutical Scientific Journal right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
